Descriptor English: | Enhancer of Zeste Homolog 2 Protein | ||||||
Descriptor Spanish: |
Proteína Potenciadora del Homólogo Zeste 2
| ||||||
Descriptor Portuguese: | Proteína Potenciadora do Homólogo 2 de Zeste | ||||||
Descriptor French: | Protéine-2 homologue de l'activateur de Zeste | ||||||
Entry term(s): |
EZH2, Histone-Lysine N-Methyltransferase Enhancer of Zeste Homolog 2 Histone Lysine N Methyltransferase EZH2 Histone-Lysine N-Methyltransferase EZH2 Lysine N Methyltransferase 6 Lysine N-Methyltransferase-6 |
||||||
Tree number(s): |
D05.500.781.750.250 D08.811.913.555.500.800.200.500.500.500 D12.776.660.235.600.200.250 D12.776.664.235.800.200.250 D12.776.930.780.890.200.250 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000071221 | ||||||
Scope note: | A histone-lysine N-methyltransferase and catalytic subunit of Polycomb Repressive Complex 2. It methylates LYSINE 9 (H3K9me) and LYSINE 27 (H3K27me) of HISTONE H3, leading to transcriptional repression of the affected target gene. EZH2 also methylates non-histone proteins such as GATA4 TRANSCRIPTION FACTOR and the nuclear receptor RORA. It regulates CIRCADIAN CLOCKS via histone methylation of circadian protein gene PROMOTER REGIONS, and its repressive activity is also important for the identity and differentiation of EMBRYONIC STEM CELLS. |
||||||
Allowable Qualifiers: |
AD administration & dosage AE adverse effects AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DE drug effects DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||||
Registry Number: | EC 2.1.1.43 | ||||||
Public MeSH Note: | 2017; ENHANCER OF ZESTE HOMOLOG 2 was indexed under POLYCOMB REPRESSIVE COMPLEX 2 2013-2016, under DNA-BINDING PROTEINS and TRANSCRIPTION FACTORS 2005-2012, and under PROTEINS 2005 |
||||||
History Note: | 2017 (2005) |
||||||
DeCS ID: | 56434 | ||||||
Unique ID: | D000071221 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 2017/01/01 | ||||||
Date of Entry: | 2016/07/08 | ||||||
Revision Date: | 2018/06/19 |
-
-
CHEMICALS AND DRUGS
Macromolecular Substances [D05]Macromolecular Substances -
CHEMICALS AND DRUGS
Enzymes and Coenzymes [D08]Enzymes and Coenzymes -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins
|
Enhancer of Zeste Homolog 2 Protein
- Preferred
Concept UI |
M000613664 |
Scope note | A histone-lysine N-methyltransferase and catalytic subunit of Polycomb Repressive Complex 2. It methylates LYSINE 9 (H3K9me) and LYSINE 27 (H3K27me) of HISTONE H3, leading to transcriptional repression of the affected target gene. EZH2 also methylates non-histone proteins such as GATA4 TRANSCRIPTION FACTOR and the nuclear receptor RORA. It regulates CIRCADIAN CLOCKS via histone methylation of circadian protein gene PROMOTER REGIONS, and its repressive activity is also important for the identity and differentiation of EMBRYONIC STEM CELLS. |
Preferred term | Enhancer of Zeste Homolog 2 Protein |
Entry term(s) |
EZH2, Histone-Lysine N-Methyltransferase Enhancer of Zeste Homolog 2 Histone Lysine N Methyltransferase EZH2 Histone-Lysine N-Methyltransferase EZH2 Lysine N Methyltransferase 6 Lysine N-Methyltransferase-6 |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey